Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva
Santiago De Surco, Lima, Peru
Medical clinic in the Santiago de Surco
Av. Manuel Olguín 1045, Santiago de Surco 15023
About Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Clinical Trials at Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva
During the past decade, Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee
2007-11-01
2011-11-01
Completed
1,457
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
2014-08-26
2017-06-01
Completed
650
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva"
#1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva
According to Clinical.Site data, the most researched conditions in "Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva" are
"Arthritis, Rheumatoid" (1 trials), "Osteoarthritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva
Most popular intervention types in "Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ibuprofen" (1 trials), "Infliximab" (1 trials), "Naproxen" (1 trials), "PF-06438179" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva
The vast majority of trials in "Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva" are
3 trials for "All" genders.
Clinical Trials Status at Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva
Currently, there are NaN active trials in "Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Ginecologia y Reproducción & Cirugia Minimamente Invasiva, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".